RxDoctor Payments DataLook up a doctor →

Christopher Colopinto, DO

Family Medicine · Camden, NJNPI 1659341923

Payments from drug & device makers

$19,651in general payments, 2019–2025

Across 1,013 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • Johnson & Johnson$3K
  • Amgen$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$2K
  • AbbVie$1K
  • Kowa Pharmaceuticals America, Inc.$1K
  • plus $7K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca62$3,059
Johnson & Johnson(2 entities)21$2,519
Amgen(2 entities)213$2,493
Takeda Pharmaceuticals U.S.A., Inc.18$1,846
AbbVie(2 entities)149$1,348
Kowa Pharmaceuticals America, Inc.81$1,244
Novo Nordisk38$686
Merck44$673
Sanofi-aventis U.S. LLC33$628
Otsuka America Pharmaceutical, Inc.29$570
Astellas Pharma US Inc18$557
Boehringer Ingelheim62$548
Pfizer50$529
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC43$459
Idorsia Pharmaceuticals US Inc14$219
Bayer7$214
Lilly USA, LLC14$214
GSK12$169
E.r. Squibb & Sons, L.L.C.4$149
Lundbeck LLC9$148
Madrigal Pharmaceuticals1$141
Novartis14$120
Alkermes, Inc.7$113
Esperion Therapeutics, Inc.8$110
Amarin Pharma, Inc.7$96
Biohaven Pharmaceuticals, Inc.4$65
Axsome Therapeutics, Inc.4$59
Currax Pharmaceuticals LLC4$55
Nestle Healthcare Nutrition Inc.4$52
Corcept Therapeutics3$51
Biohaven Pharmaceutical Holding Company Ltd.3$45
OPKO Pharmaceuticals, LLC3$41
Exact Sciences2$39
Hologic Sales And Service, LLC2$35
Irhythm Technologies, Inc.2$31
Qiagen, LLC2$26
Ardelyx, Inc.1$23
Hikma Pharmaceuticals USA1$21
Dexcom, Inc.1$19
Althera Pharmaceuticals LLC2$19
Arbor Pharmaceuticals, Inc.1$17
Modernatx, Inc.1$17
Seqirus USA Inc1$17
Gilead1$16
Lupin Inc.1$15
Collegium Pharmaceutical, Inc.1$14
Biodelivery Sciences International, Inc.1$14
Aimmune Therapeutics, Inc.1$14
USWM, LLC1$14
Eisai Inc.1$13
Phathom Pharmaceuticals, Inc.2$13
Ortho Dermatologics, A Division Of Bausch Health US, LLC1$13
Genentech USA, Inc.1$12
Assertio Therapeutics, Inc.1$12
Sanofi Pasteur Inc.1$12
Clarus Therapeutics Inc.1$7

How this compares

$19,651 in reported general payments places this provider in the 95th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024
$232,050
Medicare patients
494
Services billed
4,326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Camden

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →